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Abstract
Background: The molecular etiology is still to be identified for about half of the
currently described Mendelian diseases in humans, thereby hindering efforts to find
treatments or preventive measures. Advances, such as new sequencing technologies,
have led to increasing amounts of data becoming available with which to address
the problem of identifying disease genes. Therefore, automated methods are needed
that reliably predict disease gene candidates based on available data. We have
recently developed Exomiser as a tool for identifying causative variants from exome
analysis results by filtering and prioritising using a number of criteria including the
phenotype similarity between the disease and mouse mutants involving the gene
candidates. Initial investigations revealed a variation in performance for different
medical categories of disease, due in part to a varying contribution of the phenotype
scoring component.
Results: In this study, we further analyse the performance of our cross-species
phenotype matching algorithm, and examine in more detail the reasons why disease
gene filtering based on phenotype data works better for certain disease categories
than others. We found that in addition to misleading phenotype alignments
between species, some disease categories are still more amenable to automated
predictions than others, and that this often ties in with community perceptions on
how well the organism works as model.
Conclusions: In conclusion, our automated disease gene candidate predictions are
highly dependent on the organism used for the predictions and the disease
category being studied. Future work on computational disease gene prediction using
phenotype data would benefit from methods that take into account the disease
category and the source of model organism data.
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Background
Despite many success stories in the identification of genetic causes for human heritable
diseases, half of the currently described disorders with a presumed genetic etiology are
still without an identified molecular basis [1]. Although the identification of a novel
disease gene rarely leads to immediate, novel treatment options, clearly an understand-
ing of the cellular pathways and networks affected by a genetic mutation is the basis
for developing improved treatment strategies and optimal genetic counseling. To sup-
port the identification of genetic causes, and with that treatment of human heritable
disorders, biological as well as computational methods have been developed [2-7].
However, none of the existing solutions is capable of providing reliable answers for all
diseases and improvements are still needed.
Technology advances have led to solutions enabling rapid and cheap identification of
variants in human genomes and exomes. However, these methods yield long lists of var-
iants reflecting the fact that each individual harbours more than 30,000 variants identifi-
able by exome sequencing, with typically 5% or more of variants not being listed in
databases of variants such as dbSNP. Typical bioinformatic filtering procedures remove
common variants and those deemed to be nonpathogenic, but are not able to narrow the
search down to only a short list of candidates based only on the sequence variants.
In a recent study, we presented the PHenotypic Interpretation of Variants in Exomes
(PHIVE) algorithm that in addition to traditional variant filtering and evaluation also
includes the phenotype manifestations in individuals as well as the signs and symptoms
of diseases [8]. It was shown that including phenotype information into the prioritisa-
tion of candidate genes leads to an up to 54.1 fold improvement over methods purely
based on variant information. To assess the phenotypic suitability of a gene variant,
PhenoDigm’s phenotype comparison algorithm was used [4]. The study also showed
that the performance of the PHIVE algorithm is influenced by the mode of inheritance
(autosomal dominant vs. autosomal recessive) and by the class of mutation (nonsense
and missense mutations). However, our investigations did not include an evaluation of
the characteristics of the diseases in question.
Ongoing debates highlight that model organisms do not necessarily constitute ideal
fits for certain diseases [9], due to e.g. changes in gene expression [10], but can still
provide valuable insights into a disease even though only part of the phenotypes may
be reproduced in a model organism [11,12]. To facilitate the linkage of model organ-
isms and diseases, ongoing efforts such as the International Mouse Phenotyping
Consortium (IMPC) and the Zebrafish Mutation Project (ZMP) record a range of pre-
defined parameters that are not just restricted to phenotypes related to the disease
area a researcher is studying [13].
The number of automated disease gene candidate prediction tools using cross-species
information is also increasing [14,4,6,5]. The aforementioned tools rely on the availability
of logical definitions for phenotypes that allow their comparison across species [15].
Typically, precision and recall measures for known gene-disease association are reported
to give an indication about the potential of the method and its suitability to the task of
disease gene candidate identification. While Börnigen et al. worked on unbiased evalua-
tion of the tools [16], to our knowledge, no further evaluation for performance of differ-
ent disease categories has been undertaken. Tools that use model organism data for the
prediction are limited not only to the availability of sufficient and unbiased experimental
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data, but are also restricted to disease areas where model organisms recapitulate the
disease and where the phenotype associated genes are orthologous.
In this study, we analysed Exomiser’s performance with respect to disease categories
provided by Orphanet [17]. As the performance of Exomiser is influenced by the Phe-
noDigm phenotype comparison algorithm, we based our experiments on the evaluation
of PhenoDigm and its applicability to disease categories. Using known gene-disease
associations in the Orphanet and Online Mendelian Inheritance in Man (OMIM) data-
bases [1], we identified areas for further improvements that will consequently influence
Exomiser’s performance. Although we only currently use PhenoDigm’s mouse-based
predictions in Exomiser, we plan to take advantage of zebrafish phenotypes amongst
other model organism data in the future as part of our participation in the Monarch
Initiative. Hence, we performed our assessment across both mouse and zebrafish data.
One factor in the poorly performing disease categories was the sub-optimal imple-
mentation of our approach for certain phenotype annotations, leading to missing
phenotype alignments. These will be addressed in future releases. Other clinical pheno-
types were not matched because they can not be accurately observed in the model
organism in question. Interestingly, some perceptions of how well or how easily different
model organisms can be fitted to particular disease areas are mirrored in the evaluation
results. We conclude that automated prediction methods could potentially benefit from
taking into consideration the categories of disease in which semantic model organism
phenotype matching works best.
Results and discussion
Exomiser provides functionality to filter and prioritize gene variant lists using our PHIVE
algorithm which combines phenotype comparisons from PhenoDigm in addition to allele
frequency and pathogenicity scores [8]. Our benchmarking of Exomiser was based on
28,516 known disease-causing mutations from the Human Gene Mutation Database [18].
Using Orphanet’s disease categorisation [19], we further divided Exomiser’s evaluation
exome data sets by disease category. Figure 1 shows that Exomiser’s ability to identify the
disease causing genes using the PHIVE algorithm varies for the different disease cate-
gories. All results fall into the range of 35 to 78%, with best performance in the gastroen-
terological diseases category. Figure 1 also shows the performance of Exomiser if only the
phenotype prioritization for genes is used but not allele frequency and pathogenicity. It is
apparent that the phenotype score works better for some disease categories than for
others. For example, in the case of gastroenterological diseases the phenotype comparison
seems to contribute a lot to the identification of disease gene candidates while in the case
of surgical maxillo facial diseases, the contribution seems to be comparatively small. Note
that not all of Orphanet’s disease categories are represented due to the limited coverage in
our evaluation set of 28,516 known disease-causing mutations.
As the PHIVE algorithm combines PhenoDigm, allele frequency and pathogenicity
prioritisation as well as some pre-filtering steps, evaluation of just the performance of the
phenotype comparison is problematic. Therefore, we decided to further investigate the
effect of disease category on phenotype comparisons by just looking at the performance of
PhenoDigm. Due to the inclusion of these other steps in Exomiser, we do not expect
observations based on PhenoDigm performance for different disease categories to translate
directly to Exomiser but should indicate potential categories where we may see enhanced
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or reduced performance. In addition, PhenoDigm covers all of OMIM and Orphanet as
well as including zebrafish so we were able to perform a more extensive evaluation of the
influence of disease categories on gene candidate predictions from model organism
phenotypes.
Analogous to the evaluation of Exomiser, we divided the diseases covered in Pheno-
Digm into the disease categories provided by Orphanet and known gene-disease asso-
ciations contained in Orphanet and OMIM. We then assessed precision and recall
over the different ranks of diseases genes and determined the Area Under Curve
(AUC) of the corresponding Receiver Operating Characteristic (ROC) curve. The AUC
measures obtained for the individual disease categories and both the species (mouse
and zebrafish) are presented in Table 1. AUC measures in mouse vary in the range of
[0.774, 0.901] and in zebrafish in the range of [0.540, 0.835]. These results show that
AUC measures calculated over all diseases may mask disease categories that are per-
forming well, e.g. zebrafish performs better than mouse for cardiac malformations
although the overall performance is much worse.
Comparing the two model organisms, the most striking observations are first of all,
that the performance for zebrafish for nearly all disease categories is reduced and sec-
ondly, that performance is much more dependent on the disease category than it is for
the mouse. Given the species-divide between human and zebrafish compared to
mouse, some of this reduced performance and increased variability maybe expected.
Figure 1 Performance of PHIVE score in Exomiser by Orphanet disease category, together with just
the phenotype-based scores. The number of diseases tested for each category are shown in parentheses.
Note that many diseases belong to multiple disease categories. The overall PHIVE performance and the
contribution of the phenotype score used in Exomiser is seen to vary with respect to the disease category.
The highest contribution of the phenotype score is in the category of gastroenterological diseases, the
smallest in the category of abdominal surgical diseases.
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Although many of the organ systems and biological processes are similar in the zebrafish,
some differences obviously exist that will affect certain disease categories more than
others. However, much of the difference could also be due to focus of research using these
different model organisms as well as varying technical difficulties with applying our
semantic comparison approach to the different phenotype ontologies used for human,
mouse and fish.
An additional factor, may be the extra difficulty of assigning orthology between
human and zebrafish genes due to the greater evolutionary distance. In addition, many
Table 1 PhenoDigm performs best for urogenital diseases for mouse and cardiac








abdominal surgical 104 0.856 (0.336) 67 0.716
(0.033)
Allergic 5 - 0 -
Bone 368 0.870 (0.002) 185 0.650 (0.110)
cardiac 128 0.857 (0.138) 58 0.675
(0.049)
cardiac malformations 34 0.822 (0.221) 23 0.835 (1E-4)
circulatory system 63 0.825 (0.239) 31 0.658 (0.417)
developmental anomalies in
embryogenesis
943 0.852 (0.177) 475 0.673 (1E-4)
endocrine 307 0.874 (0.029) 128 0.629 (0.382)
eye 582 0.864 (0.034) 269 0.646 (0.147)
gastroenterological 74 0.842 (0.391) 36 0.739
(0.031)
haematological 151 0.816 (0.151) 53 0.603 (0.215)
hepatic 41 0.774 (0.011) 8 -
immunological 134 0.843 (0.391) 36 0.540
(0.014)
inborn errors of metabolism 384 0.789 (5E-9) 91 0.646 (0.103)
infectious 3 - 2 -
infertility 41 0.817 (0.154) 18 0.635 (0.496)
neurological 777 0.787 (2E-11) 328 0.630 (0.486)
odontological 44 0.899 (0.078) 18 0.693 (0.161)
otorhinolaryngological 150 0.890 (0.043) 74 0.731
(0.015)
renal 277 0.846 (0.479) 130 0.676
(0.048)
respiratory 65 0.808 (0.126) 35 0.594 (0.135)
skin 418 0.852 (0.161) 154 0.636 (0.442)
surgical maxillo facial 89 0.836 (0.367) 56 0.723 (5E-4)
surgical thoracic 33 0.816 (0.176) 12 0.641 (0.364)
systematic and rheumatological 68 0.832 (0.297) 14 0.592 (0.311)
teratologic 1 - 1 -
tumors 239 0.835 (0.388) 130 0.677
(0.044)
urogenital 62 0.901 (0.050) 31 0.608 (0.207)
all diseases 3728 0.845 1558 0.630
* disease categories according to Orphanet [19]; † number of diseases falling into this category with phenotype data for
the orthologue(s) of the associated gene; ‡ AUC, measured on disease-gene associations from OMIM’s MorbidMap and
Orphanet curation. Value in brackets shows the p-value of obtained this result compared to those obtained from
randomly selecting the same number of diseases. Significant results (p value <0.05) are shown in bold. Note that one
disease may fall into different categories due to multiple systems affected by disease.
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of the genes are part of a genome duplication event in zebrafish so that one human
disease gene may correspond to two zebrafish genes and it may take disruption of
both to recapitulate the clinical phenotypes.
To investigate some of these issues we analysed the annotations and the corresponding
PhenoDigm matches in more detail for the best, intermediate and worst performing dis-
ease categories. In addition to the calculation of AUC measures, we further investigated
six of the disease categories (three for each species) to obtain a better understanding of
the shortcomings of either the method or the data. For each disease category, we investi-
gated the 10 most common clinical phenotypes and their best matches in the model
organism phenotypes.
Investigation of mouse model prediction results
To identify reasons for the differences in performances with respect to the applied disease
categories, we further investigated the following three categories of diseases: urogenital,
hepatic and neurological diseases. We studied their annotations and the corresponding
best phenotype matches in mouse produced by PhenoDigm, together with potential biolo-
gical reasons for differences in performance. The results for each of the three further
investigated disease categories are shown in Additional File 1 and discussed in more detail
in the following sections.
Urogenital diseases
The ten most frequently occurring clinical Human Phenotype Ontology (HPO) pheno-
types in this category include expected urogenital phenotypes such as Cryptorchidism
as well as others such as Short stature, Microcephaly and Cognitive impairment. The
latter are due to the Orphanet classification allowing diseases to be assigned to multi-
ple categories e.g. many diseases may be classified as both urogenital and neurological
leading to a preponderance of both urogenital and neurological phenotypes when looking
at each individual category.
The common urogenital and other types of clinical phenotypes all matched the expected
mouse phenotypes in Mammalian Phenotype Ontology (MP) (and their more specific
child terms when present) with the exception of Cognitive impairment. Cognitive impair-
ment was the 10th most commonly observed clinical phenotype in this disease category
and is obviously a more difficult phenotype to measure in a mouse model than physical
abnormalities such as Cryptorchidism and there is no directly corresponding MP equiva-
lent term. Hence, PhenoDigm ends up matching numerous general abnormalities of
higher mental function such as increased anxietyrelated response (MP:0001363) which will
lead to Cognitive impairment not being an informative phenotype for selecting specific
mouse model matches.
The specific recall for most of the associated clinical phenotypes increases the likelihood
of mouse models being predicted that are relevant to the urogenital diseases. Assuming
also, that mouse models disrupting the known urogenital disease genes produce a pheno-
copy of the disease, then performance of PhenoDigm would be expected to be good for
this category as was observed.
Hepatic diseases
Useful animal models of liver disease have only very recently been identified [20], so it is
perhaps not surprising that we found that this disease category to be the worst performing
for mouse. Despite the fact that mice do not necessarily constitute a “good” model
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organism to study hepatic diseases, we still investigated the phenotype matches together
with the predicted disease models for this disease category.
In contast, to some of the other disease categories, the ten most frequently occurring
phenotypes were all consistent for hepatic disease rather than some being a consequence
of Orphanet’s classification of certain diseases to multiple categories. Eight of these most
frequent occurring clinical phenotypes recalled the expected mouse phenotype as the best
match in MP (and their child terms if they existed). For example, Figure 2a shows Pheno-
Digm results in Hepatomegaly matching enlarged liver, liver hyperplasia and increased
liver weight as the best mouse phenotypes.
The other two concepts mapped sub-optimally or produced completely misleading
results. For example, Figure 2b shows how the HPO concept Pruritus is matched to
abnormal skin physiology as the best hit in mouse as well as all its child terms due
to the lack of logical definitions for Pruritus (HP:0000989) and increased pruritus
(MP:0010072). Although the 28 child terms include the ideal match, the additional
matches will lead to non-specific mouse models being recovered. Finally, the best
matches for the HPO concept Elevated hepatic transaminases (HP:0002910) were
increased liver copper level and increased liver iron level based purely on increased
concentrations of any object in the liver. Even though a corresponding MP concept
exists, increased circulating aspartate transaminase level (MP:0005343), the correct
logical definitions do not yet exist for PhenoDigm to have identified this
relationship.
Figure 2 Relationships between common HPO clinical phenotypes for the hepatic disease class and
MP terms. (a) The HPO term for Hepatomegaly is identified as being equivalent to the MP term for
enlarged liver via their logical definitions. This MP term and its children are identified as the best scoring
matches. (b) Lack of a logical definition for Pruritis leads to the best scoring MP matches being to the
higher level term of abnormal skin physiology and all of its multiple child terms, many of which having no
relationship to pruritis.
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Although the performance could be improved if accurate logical definitions were created
for the two poorly-mapped phenotypes, the fact that the others matched the expected
mouse phenotypes as the best hit suggests that the poor overall performance of Pheno-
Digm in this disease category may be due to mouse mutants of hepatic disease genes not
recapitulating the same phenotypes.
Neurological diseases
In previous studies it has been found that there are sufficient commonalities between
humans and mice to determine disease gene candidates for some of the diseases belong-
ing to the category of neurological diseases, e.g. diseases related to addiction [21].
However, there are still differences between mice and humans related to gene structure
and spatiotemporal expression patterns that may prevent mice being in general applicable
to neurological diseases [12]. Despite a mouse model not faithfully recapitulating a human
disease, the mouse model may still provide insights into the origin of the disease [11].
The ten most commonly occurring HPO annotations in this category included two that
do not have a neurological basis but are due to Orphanet’s co-classification of diseases:
Short stature and Scoliosis. However, both match the expected terms as the best hit in MP
and their inclusion would therefore not be expected to account for the relatively poor
performance of PhenoDigm for this disease category.
Looking at just the eight neurological phenotypes, four match the expected terms in MP
and their child terms where present: Seizures, Muscular hypotonia, Microcephaly and
Nystagmus. The other four only match high level terms in MP and all their child terms as
the best scoring hits: Cognitive impairment, Intellectual disability, Global developmental
delay and Hyperreflexia. These multiple matches lead to an imprecision when mouse
models are ranked according to their phenotype similarity with the disease. This poten-
tially leads to noisy results as multiple models are associated that are not necessarily rele-
vant for the disease but due to the misaligned phenotypes. These issues in semantically
mapping behavioural phenotypes may account for a large proportion of the poor perfor-
mance in this disease category as opposed to underlying problems with using mice to
model the biology of neurological diseases.
Investigation of zebrafish model prediction results
To identify reasons for the differences in performances with respect to the applied dis-
ease categories, we further investigated the following three categories of diseases: cardiac
malformations, immunological and bone diseases. We studied their annotations and the
corresponding matches from PhenoDigm and the results are summarised in Additional
File 1.
Cardiac malformations
The main reason for zebrafish’s adoption as a model organism is the translucency of the
organism in the embryonic stage, allowing in vivo, non-intrusive visualisation of organs as
well as biological processes. Therefore, zebrafish are ideal model systems for studying
developmental diseases and this may go some way to explaining why zebrafish outper-
formed mouse as a model of the congenital cardiac malformations in our analysis.
We observe that the most common clinical phenotype annotations in this disease
category are matched efficiently by PhenoDigm. For example, Abnormality of the aorta
(HP:0001679) matches various more specific aortic abnormalities in the Zebrafish
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Phenotype Ontology (ZP) annotations, whilst the clinical phenotypes Defect in the
atrial septum (HP:0001631) and Ventricular septal defect (HP:0001629) are best
aligned with the zebrafish phenotype abnormally closed atrioventricular node. Tetral-
ogy of Fallot (HP:0001636) in itself comprises four separate phenotypes and here only
matches abnormally aplastic ventricular endocardium epithelium as the best hit which
is only a close association at best. In contrast, Patent ductus arteriosus (HP:0001643)
does not match any sensible zebrafish phenotype but closure of the ductus arteriosis
on birth, allowing the lungs to get their own supply of blood, is known to be a specific
aspect of air-breathing vertebrates [22].
Many of the non-cardiac associated annotations seen in this disease category match
less well to the fish phenotypes but are also less commonly seen and the cardiac
matches alone appear to have been enough to efficiently recall the correct zebrafish
models for most cardiac malformations. For example, no match to Cognitive impair-
ment (HP:0100543) is retrieved and Microcephaly (HP:0000252) is aligned with abnor-
mally decreased thickness cranial nerve VIII as the best match. Future investigation of
why zebrafish phenotypes such as abnormally hypoplastic head were not the best hit
for Microcephaly and some of the learning/memory fish phenotypes were not picked
up for Cognitive impairment may further improve recall.
Immunological diseases
Although the zebrafish immune system closely approximates that of mammals, the
main use of zebrafish in immunology comes from the fact that the embryonic stage
already has a fully competent innate immune system allowing contrasting studies with
the adaptive system [23]. One explanation for the poor performance in this disease
category is that human adult immune phenotypes from a mixture of innate and adap-
tive responses are being compared to zebrafish embryonic innate phenotypes. The
most common clinical phenotypes seen in this category are Splenomegaly
(HP:0001744) and Hepatomegaly (HP:0002240) and these match the expected ZP
terms of abnormally increased size spleen and abnormally increased size liver as the
best scoring hits. However, other common clinical annotations such as Recurrent bac-
terial or respiratory infections (HP:0002718, HP:0002205) are not matched to anything
in the zebrafish annotations beyond generalized immune system abnormalities. Recur-
rent infections suggest a long-lasting loss of protective immunity due to a perturbance
in the adaptive immune system and as described above, this would not be observed in
the embryonic zebrafish stages.
Other common immunological annotations in this category include Lymphadenopa-
thy (HP:0002716), Anemia (HP:0001903), Neutropenia (HP:0001875) and Thrombocyto-
penia (HP:0001873) but none of these match the expected phenotypes in the zebrafish
as the best scoring hit using our approach. The fact that zebrafish lack lymph nodes
explains the first one but there are fish annotated with abnormally present in fewer
numbers in organism nucleate erythrocyte , abnormally present in fewer numbers in
organism neutrophil and abnormally present in fewer numbers in organism thrombo-
cyte, so it would be expected that the clinical phenotypes should have recalled these
fish phenotypes. Investigation and restructuring of the underlying ontologies and/or
logical definitions to pick up these matches would presumably lead to an improvement
in performance for this disease category.
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Bone diseases
Despite having a different skeletal organisation, zebrafish has recently emerged as a use-
ful complementary model for bone research due to the ability to study in vivo, processes
such as osteogenesis and mineralization thanks to the existence of osteoblast-specific
reporter lines [24].
Using PhenoDigm, the performance was mid-range for this disease category relative
to the others. Looking at the most common skeletal clinical phenotypes we find that
some match to the equivalent concepts in zebrafish whilst others warrant further
attention. For example the most common clinical phenotype, Short stature
(HP:0004322), is completely mis-matched to abnormally decreased height enterocyte as
the best match. Fixing our approach such that abnormally decreased length whole
organism is the best match would probably lead to a dramatic increase in performance.
Other matches such as Scoliosis (HP:0002650) with abnormally curved lateral vertebral
column, Micrognathia (HP:0000347) with abnormally aplastic dentary and Brachydac-
tyly syndrome (HP:0001156) with abnormally aplastic pectoral fin skeleton are reason-
able considering the evolutionary distance.
Conclusions
Exomiser is a tool to narrow down gene candidate lists that have been identified in
exome analyses using cross-species phenotype comparisons amongst other sources of
evidence. Here we investigated the underlying PhenoDigm algorithm for different disease
categories to understand where the approach is currently working well and to identify
areas for further improvement. We demonstrated that the phenotype comparisons work
better for some disease categories than for others. Furthermore, the prediction results
depend on the organism and when automatically predicting disease gene candidates
careful consideration is required as to which organism to apply for the predictions.
However, it is somewhat difficult to disentangle whether performance differences exist
due to differences in biology, the annotation methods used for each species or the focus
of annotations for mouse and fish.
In addition to the identified biological restrictions that partially mirror community per-
ceptions of how well the model organism can be fitted to human diseases, we showed that
the underlying methodology still needs improvements. Even though a lot of work has
been done in this direction, more logical definitions are needed in addition to improving
the quality of the existing definitions to improve semantic mapping between the species-
specific phenotype ontologies. Future work, will focus on improving these definitions and
will undoubtably lead to improvements in the performance of PhenoDigm and Exomiser.
Even with a perfectly aligned set of phenotype ontologies, our results highlight that it
will be dangerous to discount a model just because it does not perfectly match all the
clinical phenotypes of the disease. For example, matches to clinical phenotypes such as
lymphadenopathy were not seen in our assessment of the zebrafish results due to the
lack of lymph nodes in fish rather than our alignment approach. In addition, different
areas of interest of the researchers who phenotype the models need to be taken into
account when using model organism to understand the genetic basis of disease i.e. par-
ticular phenotypes may not have been assessed. In conclusion, smarter tools are
required that take into account the differences between species and accumulate
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predictions not only over multiple species but apply a sorting with respect to the
applicability of the species in the particular area of disease.
Methods
Benchmark data: MorbidMap and Orphanet
Assessing the performance of a gene prediction or prioritisation algorithm requires
benchmark data containing established gene-disease associations. One database con-
taining manually confirmed associations between human diseases and genes is OMIM
[1]. The human-centric gene-disease associations from OMIM are available via a
download file called MorbidMap [25]. In addition we used the disease-gene associa-
tions curated by Orphanet. Both OMIM and Orphanet have HPO annotations that can
be used by PhenoDigm and both were downloaded on 20 July 2013 and Mouse
Genome Database (MGD)’s orthology file (see [26]) was used to convert the genes into
mouse-specific gene identifiers that can be used for evaluation purposes. The final
dataset contained a total of 3,429 diseases associated with 2,662 unique genes, which
mapped to 2,772 orthologous genes in mouse and 1862 in fish.
Generating prediction results with PhenoDigm
PhenoDigm [4] uses phenotype descriptions of human heritable disease and individual
animal models to predict potentially gene candidates that may be causative for a dis-
eases. The PhenoDigm algorithm uses a pairwise semantic similarity based on pheno-
type ontology annotations, such as HPO or MP, and prioritises genes according to this
similarity measure. Applying the PhenoDigm method, a database was generated con-
taining all the results displayed in the online web interface [27]. Instead of regenerating
the data, we used the data built from 20 July 2013 so that the results presented here
correspond with the current publicly available data.
Dividing diseases into sets according to Orphanet categorisation
To divide the disease into sets that are biologically meaningful, we downloaded the Orpha-
net categorisation files from the Orphanet data download page [19] on 18 July 2013. We
downloaded and processed 31 data files, one for each of the high level disease categories
in the Orphanet categorisation. Each of the files contains a number of diseases that may
or may not be referenced to OMIM. Furthermore, a disease may not only be assigned to
one category and instead be mentioned in multiple files. For example, X-linked myotubu-
lar myopathy (OMIM:#310400) is categorised as a rare eye and neurological disorder
because the most prominent symptoms include weakness, hypotonia and respiratory
failure, as well as external ophthalmoplegia.
We note here that the Orphanet web interface also provides a category of sucking/
swallowing disorders. This disease category was not included here as no categorisation
file was provided on the Orphanet download page [19].
Assessing PhenoDigm’s performance according to disease categories
To determine PhenoDigm’s performance, we applied ROC curves based on the gene-
disease associations (see Benchmark data: MorbidMap and Orphanet ). We divided
the diseases into sets according to Orphanet’s categorisation (see Dividing diseases into
sets according to Orphanet categorisation) and consequently generated 31 evaluation
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sets. PhenoDigm’s ranking was then compared using the 31 evaluation sets corre-
sponding to each of the disease categories by determining true and false positive
counts individually for each rank. As true positive counts a gene that is associated to a
disease in MorbidMap or Orphanet. Conversely, a gene that is not mentioned in
MorbidMap or Orphanet for a particular disease counts as false positive. We note
here, that gene-disease associations may be counted as falsely identified connections,
even though there is a relationship but it is not yet confirmed. However, we assume
that this number is relatively small compared to the large number of possible combina-
tions of genes and diseases and assume that our evaluation procedure is still appropri-
ate. As a consequence, the true predictive rates provided here may be lower than they
are in reality. To test the significance of each ROC analysis we performed 50 simulations
per disease category where a set of diseases of the same size as the evaluation set was
randomly chosen. These simulations provided a mean and standard deviation for the
random distribution of scores for each evaluation set and these were used to calculate a
p-value for the obtained result.
Manual assessment of six disease categories
Further investigations into individual disease categories were necessary to identify
potential shortcomings in either method or data. We chose six categories of diseases
based on the worst, best, and one intermediate AUC score for each species (mouse
and zebrafish). Two curators assessed the phenotype matches to either mouse or fish
(see Additional File 1) for the ten most frequently occuring phenotypes accumulated
over all the diseases falling into this category. The matches were assessed with respect
to their biological correctness and whether they were sufficiently suitable to identify
models from the respective organism.
Additional material
Additional file 1: Annotations and their matches for urogenetial, hepatic and neurological diseases with
respect to mouse and fish models. Excel sheet that contains the HPO annotations for the six further
investigated disease categories: urogenital, neurological, hepatic, cardiac malformations, bone and immunological.
In addition to the ten most frequent HPO annotations, we included the best scoring semantic matches to the
respective model organism (either MP or ZP) as well as the frequency of this annotation.
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